These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 7971612

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Antacids and anticholinergics in the treatment of duodenal ulcer.
    Walan A.
    Clin Gastroenterol; 1984 May; 13(2):473-99. PubMed ID: 6086186
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Movement of gastric acid secretion and influence of proton pump inhibitors on histamine H2 receptor antagonist resistant ulcer].
    Asaki S, Kimpara T, Ohara S, Hongo M.
    Nihon Rinsho; 1992 Jan; 50(1):111-5. PubMed ID: 1347323
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Proton pump inhibitors and acid-related diseases.
    Sachs G.
    Pharmacotherapy; 1997 Jan; 17(1):22-37. PubMed ID: 9017763
    [Abstract] [Full Text] [Related]

  • 31. [The status of H2-blocker therapy today].
    Rameis H.
    Wien Med Wochenschr; 1992 Jan; 142(18):398-405. PubMed ID: 1362029
    [Abstract] [Full Text] [Related]

  • 32. [A gastroenterologist's choice: proton pump inhibitors of H2 histamine receptor blockers in the treatment of peptic ulcer].
    Morozov IA.
    Klin Med (Mosk); 2001 Jan; 79(5):68-71. PubMed ID: 11510196
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Current aspects of the therapy of gastroduodenal peptic ulcer].
    Castro Lde P.
    Rev Hosp Clin Fac Med Sao Paulo; 1983 Jan; 38(2):90-102. PubMed ID: 6139870
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The influence of feeding on gastric acid suppression in Helicobacter pylori-positive patients treated with a proton pump inhibitor or an H2-receptor antagonist after bleeding from a gastric ulcer.
    Ozawa T, Yoshikawa N, Tomita T, Akita Y, Mitamura K.
    J Gastroenterol; 2003 Jan; 38(9):844-8. PubMed ID: 14564629
    [Abstract] [Full Text] [Related]

  • 38. Why is the high grade inhibition of gastric acid secretion afforded by proton pump inhibitors often required for healing of reflux esophagitis? An epithelial perspective.
    Orlando RC.
    Am J Gastroenterol; 1996 Sep; 91(9):1692-6. PubMed ID: 8792683
    [Abstract] [Full Text] [Related]

  • 39. pH, healing rate, and symptom relief in patients with GERD.
    Huang JQ, Hunt RH.
    Yale J Biol Med; 1999 Sep; 72(2-3):181-94. PubMed ID: 10780580
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.